Pharmaceutial & Healthcare

25-mar-2019 Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert). Pharmacokinetically, it resembles basal insulin secretion of non-diabetic pancreatic beta cells. Sometimes, in type 2 diabetes and in combination with a short acting sulfonylurea (drugs which stimulate the pancreas to make more insulin), it can offer moderate control of serum glucose levels. In the absence of endogenous insulin-type 1 diabetes, depleted type 2 (in some cases) or latent autoimmune diabetes of adults in late stage-insulin glargine needs the support of fast acting insulin taken with food to reduce the effect of prandially derived glucose. This report provides detailed analysis of w...

25-mar-2019 The Viaminate Market 2017 Report offers detailed analysis of the Viaminate market over the last five years, and provides extensive market forecasts by region/country and sub sector. It covers the key technological and market trends in the Viaminate market . It further lays out an analysis of the factors influencing the supply/demand for Viaminate, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. In particular, it provides an in-depth analysis of the following: Market overview: detailed analysis of the whole value chain (upstream & downstream), insights into technological developments, and an extensive analysis of costs analysis from the aspects of raw materials, labor costs and etc. Market size and driving factors: comprehensive analysis of the global Viaminate market...

25-mar-2019  It is anticipated to expand at a CAGR of 6.6% during the forecast period. Increasing cost of drug development is expected to drive the growth. Drug maker and sponsor companies are under pressure to replace the revenue loss caused by generics, increasing patent expirations, number of partnerships to identify biologics, and growing R&D costs, which has made drug development more expensive and complex. Regulatory framework for drug discovery and drug development is complex in various countries. Thus, an increasing need for expertise in different areas of drug development is driving the demand for outsourcing services. Drug companies are not only outsourcing production of medicines, but also clinical trials. With increasing privatization of clinical trials, there has been an increase in outsourcing of manufacturing processes to developing regions such as India, China, and Latin American countries. China and India are projected to witness tremendous growth in near ...

25-mar-2019 Hospital Stretchers Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Hospital Stretchers basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) Basic Information; 2.) Asia Hospital Stretchers M...

25-mar-2019 Oncology Surgery Microscope Report by Material, Application, and Geography - Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Oncology Surgery Microscope basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with:  1.) basic information; 2.) the Asia ...

18-mar-2019 In this report, the global Ketoprofen Patches market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Ketoprofen Patches for these regions, from 2012 to 2022 (forecast), covering • United States • China • Europe • Japan • Southeast Asia • India Global Ketoprofen Patches market competition by top manufacturers/players, with Ketoprofen Patches sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including • GlaxoSmithKline • Endo International • Hisamitsu Pharmaceutical • Pfizer • Mylan • ALLERGAN On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into  B...

18-mar-2019 In this report, the global Hyperthermia Treatment for Cancer market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Hyperthermia Treatment for Cancer for these regions, from 2012 to 2022 (forecast), covering • United States • China • Europe • Japan • Southeast Asia • India Global Hyperthermia Treatment for Cancer market competition by top manufacturers/players, with Hyperthermia Treatment for Cancer sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including • Andromedic Sri • Celsius42 GmbH • Huahang • Pyrexar Medical • Perseon Medical • Omron Corporation • Sjn AG Yamamoto Vinita On the basis of product, this report displays the product...